Annual Accounts Payable
$2.88 M
+$606.00 K+26.68%
December 31, 2023
Summary
- As of February 24, 2025, CLDI annual accounts payable is $2.88 million, with the most recent change of +$606.00 thousand (+26.68%) on December 31, 2023.
- During the last 3 years, CLDI annual accounts payable has risen by +$1.90 million (+195.68%).
- CLDI annual accounts payable is now at all-time high.
Performance
CLDI Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$3.57 M
-$886.00 K-19.87%
September 30, 2024
Summary
- As of February 24, 2025, CLDI quarterly accounts payable is $3.57 million, with the most recent change of -$886.00 thousand (-19.87%) on September 30, 2024.
- Over the past year, CLDI quarterly accounts payable has stayed the same.
- CLDI quarterly accounts payable is now -19.87% below its all-time high of $4.46 million, reached on June 30, 2024.
Performance
CLDI Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
CLDI Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +26.7% | 0.0% |
| 3 y3 years | +195.7% | 0.0% |
| 5 y5 years | +195.7% | 0.0% |
CLDI Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +361.1% | -19.9% | +600.8% |
| 5 y | 5-year | at high | +361.1% | -19.9% | +600.8% |
| alltime | all time | at high | +361.1% | -19.9% | +600.8% |
Calidi Biotherapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.57 M(-19.9%) |
| Jun 2024 | - | $4.46 M(+17.2%) |
| Mar 2024 | - | $3.81 M(+36.1%) |
| Dec 2023 | $2.88 M | $2.80 M(+98.3%) |
| Sep 2023 | - | $1.41 M(+136.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $596.00 K(-71.9%) |
| Dec 2022 | $2.27 M(+263.9%) | - |
| Dec 2022 | - | $2.12 M(+0.5%) |
| Sep 2022 | - | $2.11 M(+314.5%) |
| Dec 2021 | $624.00 K(-35.9%) | $510.00 K |
| Dec 2020 | $973.00 K | - |
FAQ
- What is Calidi Biotherapeutics annual accounts payable?
- What is the all time high annual accounts payable for Calidi Biotherapeutics?
- What is Calidi Biotherapeutics annual accounts payable year-on-year change?
- What is Calidi Biotherapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Calidi Biotherapeutics?
- What is Calidi Biotherapeutics quarterly accounts payable year-on-year change?
What is Calidi Biotherapeutics annual accounts payable?
The current annual accounts payable of CLDI is $2.88 M
What is the all time high annual accounts payable for Calidi Biotherapeutics?
Calidi Biotherapeutics all-time high annual accounts payable is $2.88 M
What is Calidi Biotherapeutics annual accounts payable year-on-year change?
Over the past year, CLDI annual accounts payable has changed by +$606.00 K (+26.68%)
What is Calidi Biotherapeutics quarterly accounts payable?
The current quarterly accounts payable of CLDI is $3.57 M
What is the all time high quarterly accounts payable for Calidi Biotherapeutics?
Calidi Biotherapeutics all-time high quarterly accounts payable is $4.46 M
What is Calidi Biotherapeutics quarterly accounts payable year-on-year change?
Over the past year, CLDI quarterly accounts payable has changed by $0.00 (0.00%)